Impax Counter-Sues Shire Over Adderall XR
Impax has counter-sued Shire Pharmaceuticals, which in October launched the latest in a string of patent infringement lawsuits against Impax over its plans to launch a generic version of Shire’s attention deficit hyperactivity disorder (ADHD) drug Adderall XR.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.